Opioid and Other Substance Use Disorders Study Committee
Summary Report for the Opioid and Other Substance Abuse Disorders Study Committee.
2024 Regular Session
CogaBart Dev siteSummary Report for the Opioid and Other Substance Abuse Disorders Study Committee.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
This memorandum provides an overview of the 2017 membership of the Opioid and Other Substance Use Disorders Interim Study Committee, the origin and charge of the committee, bill request deadlines and procedures, and information regarding committee staff and the committee website. Information is...
This issue brief provides an overview of minors’ rights to deny others access to medical records under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and Colorado state law. It also discusses state law pertaining to the ability of minors to consent to medical care.
This issue brief outlines Colorado's efforts to address issues associated with persons with mental illness in the criminal justice system.
The U.S. Constitution guarantees each citizen the right to a fair trial, which includes the right to be present at the trial, able to understand the nature of the proceedings, and able to participate in his or her defense. Whether the defendant’s mental health impaired his or her ability to...
Colorado receives annual payments from tobacco manufacturers as part of the Tobacco Master Settlement Agreement. In April 2016, the state received $92.3 million. This memorandum presents the distribution of the 2016 payment and forecasts payments through 2019.
Presented to the Joint Health Committee at its meeting on January 6, 2017.